Artivion, Inc.
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impacts. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts.
Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany.
BioGlue Product Animation
AMDS – a Tool for Every Surgeon
AMDS Deployment - A first-of-its-kind device to Treat Type A Aortic Dissections
Dr. Szeto: How AMDS Nearly Eliminates DANE to Improve Long-Term Aortic Outcomes
How AMDS Democratizes Aortic Dissection Care across all cardiac surgeons and hospitals
Why AMDS Is a Game-Changer in Aortic Dissection: Better Outcomes and ease of use
Dr. Fleischman on AMDS: A Better Option for High-Risk Type A Dissection Patients
Dr. Eudailey on AMDS: Simple, Fast, and Effective for Aortic Repair
Dr. Fukuhara on the AMDS Advantage.
Dr. Eudailey: AMDS Is a Breakthrough for High-Risk Aortic Dissection with Malperfusion
Dr. Eudiley on AMDS: Simplifying Complex Type A Dissection Care with Positive Aortic Remodeling
AMDS: The First Dedicated Solution for Type A Aortic Dissection
Dr. Szeto: AMDS May Be the Future of Arch Management in Type A Dissection
Dr. Szeto: AMDS — A Life-Saving Breakthrough in Acute Type A Aortic Dissection
Dr. Moon: AMDS Delivers Exceptional Survival in High-Risk Malperfusion Patients
Artivion's Clinical Power at EACTS 2024
We Are Artivion, Inc.
Patient Success Story: Ian Craven, Out of the Blue